Latest Biotech News

A phase II GETNE-DUTHY trial evaluating durvalumab plus tremelimumab reported findings in advanced thyroid carcinoma, aiming to expand immunotherapy options for a cancer type with limited...

Researchers reported that circulating glycocholic acid (GCA) can modulate the efficacy of colorectal cancer immune checkpoint therapy. The findings, described in a study focused on tumor...

New research reported molecular profiling work designed to guide targeted and immunotherapy selection in small cell lung cancer (SCLC), a disease marked by rapid progression and heterogeneous...

Researchers from The Jackson Laboratory (JAX) reported an epigenetic strategy that reactivates the tumor suppressor ZBTB7A in acute myeloid leukemia (AML) models. In a mouse study published in...

Curve Therapeutics, a University of Southampton spinout focused on transcription factors and other intracellular targets, appointed liver specialist Amit Singal to join its leadership as...

Finance coverage highlighted that Ambrosia and Syneron are moving toward the clinic with nine-digit Series B rounds, according to the sourced financing report. The recap places the deals...

Abbott partnered with Flatiron Health to integrate Abbott’s precision oncology testing menu into Flatiron’s cloud-based electronic medical record platform, OncoEMR. The integration enables...

The Trump administration revived a pharma tariff framework with 100% charges under “Section 232,” while analysts cited exemptions and loopholes that would limit coverage across a wide set of...

Rocket Pharmaceuticals said the FDA approved its gene therapy Kresladi (marnetegragene autotemcel) for leukocyte adhesion deficiency type I, and the program earned a rare pediatric disease...

TriNetX will link its large de-identified health database with Regeneron for genomic and proteomic data access under an exclusive, secure, licensed arrangement covering roughly 300 million...

Caris Life Sciences launched Caris ChromoSeq, a combined whole-genome sequencing and whole-transcriptome assay aimed at improving clinical genomic evaluation for myeloid malignancies. The test...

Clinicians offering early access to Grail’s multi-cancer early detection (MCED) test are waiting for a full NHS trial readout after an endpoint miss, according to reporting. The situation is...

Interim results from the phase II COCOON trial showed a 50% reduction in dermatologic toxicities when proactive skincare was used in frontline EGFR-mutant non-small cell lung cancer patients. The...

Researchers at The Jackson Laboratory (JAX) reported an epigenetic approach that reactivates a tumor suppressor gene in acute myeloid leukemia models. In mouse experiments published in Science...

A new analysis examines clinical outcomes and risks following transplantation in patients with relapsed or refractory mantle cell lymphoma after ibrutinib exposure. The focus is on how targeted...

Researchers reported evidence connecting obesity with functional exhaustion of circulating γδ T cells in individuals with type 2 diabetes, tying metabolic disease severity to changes in an...

Biomedical engineers from the University of North Carolina at Chapel Hill and North Carolina State University reported development of an injectable hemostatic microgel to reduce bleeding in...

Industry stakeholders discussed the proposed EU Biotech Act as a lever to improve European biotech competitiveness, with emphasis on manufacturing supply chains and harmonized pathways to market....

FDA approved Rocket Pharmaceuticals’ gene therapy Kresladi (marnetegragene autotemcel) for leukocyte adhesion deficiency type I, the company said, making it one of the March approvals that earned...

TriNetX and Regeneron announced an agreement linking genomic and proteomic data for drug discovery and development, with TriNetX providing Regeneron exclusive, secure access to de-identified...